Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
-
Field
-
28 Feb 2026 Job Information Organisation/Company KU LEUVEN Research Field Juridical sciences » Informatic law Researcher Profile First Stage Researcher (R1) Application Deadline 19 Mar 2026 - 23:59 (UTC) Country Belgium Type of Contract Temporary Job Status Full-time Offer Starting Date 1 Sep...
-
of Contract Temporary Job Status Negotiable Offer Starting Date 30 Jun 2026 Is the job funded through the EU Research Framework Programme? Horizon Europe (other) Reference Number IPS-PS2W-05-2025 Is the Job
-
Revolutionising Infection Diagnosis Through Targeted Radiometal Imaging Background of the Project: People with conditions like heart disease, diabetes, cancer, organ transplants
-
and Physical Sciences to be undertaken within the Research Centre for Cyber Security, Privacy and Trust at Aston University, Birmingham, United Kingdom. The successful applicant will join an established
-
can read more about the department at www.es.aau.dk . Your work tasks Media distribution is undergoing radical transformations from dedicated infrastructures (e.g. DAB, FM and DVB-T) to IP based
-
activities by students enrolled in a PhD, within the scope of the project UID/00239/2025, taking place at the Forest Research Centre from the Instituto Superior de Agronomia, financed by Fundação para a
-
ophthalmoscopy: new perspectives in the diagnosis of eye diseases (Dwufotonowa oftalmoskopia czasu życia fluorescencji: nowe perspektywy w diagnostyce chorób oczu), FENG.02.02-IP.05-0121/25 Description
-
ophthalmoscopy: new perspectives in the diagnosis of eye diseases (Dwufotonowa oftalmoskopia czasu życia fluorescencji: nowe perspektywy w diagnostyce chorób oczu), FENG.02.02-IP.05-0121/25 Description
-
place at the Forest Research Centre (CEF) of the Instituto Superior de Agronomia, financed by national funds through FCT – Foundation for Science and Technology, I.P., under the following conditions: 1
-
longstanding expertise in transgenic approaches including genome editing, in cell (ES, iPS) and animal models, as well as AAV vector technologies, which are employed for generating disease models, identifying